You are here

New study spotlights disparities in COVID-19 clinical trials

Primary tabs

A study yesterday in JAMA Internal Medicine shows women and racial minorities were underrepresented in both COVID-19 clinical treatment trials and in disease prevention trials.

The research was conducted by a team from the Fred Hutchinson Cancer Center, as well researchers from Beijing and London.

"To our knowledge, this is the first study to comprehensively examine demographic representation across the landscape of both COVID-19 prevention and treatment trials over the first two years of this pandemic," said Hong Xiao, PhD, researcher in the Public Health Sciences Division at Fred Hutch and the lead author for the study, in a Fred Hutchinson press release.

...

Problem, Solution, SitRep, or ?: 
Groups this Group Post belongs to: 
- Private group -
howdy folks
Page loaded in 0.549 seconds.